Results 251 to 260 of about 66,837 (311)

Corruption in pharmaceutical sector in Pakistan.

JPMA. The Journal of the Pakistan Medical Association, 2014
Mehran, Qayum, Hassan Mehmood, Khan, Shefa Haider, Sawal   +2 more
openaire   +1 more source

Antibiotic Use Across One Health Sectors in Uganda: Temporal Alignment Between Antibiotic Introduction and Policy Guidance: A Scoping Review and Meta-Analysis

Nabisubi P, Agasi H, Namutebi S, Nabukeera KC, Akurut E, Ezinga R, Kebirungi G, Kiyaga S, Olum W, Nakanjako D, Kateete DP, Mboowa G, Jjingo D, Muwonge A, Galiwango R.   +14 more
europepmc   +1 more source

Organisation of cross-sector collaboration and its influence on crisis management effectiveness among pharmaceutical supply chain stakeholders during the COVID-19 pandemic

Public Health, 2023
Objectives: To investigate the organisation of cross-sector collaboration and how it influenced crisis management effectiveness among pharmaceutical supply chain stakeholders in Finland during the COVID-19 pandemic.
S Latonen, Anne Juppo, Marja Airaksinen   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

The Pharmaceutical Sector

2020
This chapter presents an overview of the factors involved in valuations of the pharmaceutical industry, most prominently, the FDA requirements that effectively shaped the nature and activities of these firms. The complicated regulatory drug development process, with its several tracks, increases RD both often have inflated IPOs, and both face strict ...
Richard T. Evans, Scott Hinds
openaire   +2 more sources

The Indian Pharmaceutical Sector [PDF]

, 2002
This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of drugs.
Ramesh Govindaraj, Gnanaraj Chellaraj
openaire   +1 more source

Access to Healthcare and the Pharmaceutical Sector

Cambridge Quarterly of Healthcare Ethics, 2011
Health is higher on the international agenda than ever before, and improving the health of poor people is a central issue in development. Poor people suffer from far higher levels of ill health, mortality, and malnutrition than do those better off, and their inadequate health is one of the factors keeping them poor or for their being poor in the first ...
Klaus M, Leisinger, Karin M, Schmitt
openaire   +2 more sources

Pricing Policies in the Pharmaceutical Sector

Drug Information Journal, 2002
In this article we analyze the problem of determining the price for new drugs in a market where stringent budget constraints on public expenditure exists and we suggest an innovative methodology to set drug prices. The market is characterized by asymmetry of information and a high proportion of investment in research and development, an element that ...
Capri S., Levaggi R.
openaire   +2 more sources

Pharmaceutical sector: Delicate transition

Nature, 2012
With lay-offs rife in the drug industry, life scientists and chemists are seeking fresh career paths.
openaire   +2 more sources